AVDL News Today: Stay Updated with the Latest Avadel Pharmaceuticals plc News in Real Time
Find AVDL news now at Meyka AI. Stay informed with the latest Avadel Pharmaceuticals plc stocks updates, including price news, market analysis, and expert insights.
FTSE 100 Rises 0.85% as US-Iran Deal Hopes Boost Risk Sentiment Despite UK GDP Dip
The FTSE 100 index rose by 0.85% in recent trading sessions as investor sentiment improved following renewed hopes of a potential diplomatic agreement between the United States and Iran. The positive global mood helped offset weaker economic data from the United Kingdom, where GDP figures showed a slight dip. The movement in the FTSE 100…
FDA Issues Alert: 6,408 Cases (160,200 lbs) of Farm Rich Pizza Snack Recalled Over Possible Metal Contamination
The FDA officially flagged a serious metal contamination risk on June 9, 2026. Rich Products Corp voluntarily recalled 6,408 cases totaling 160,200 pounds of Farm Rich Pizza Cheese Crunchers after the products were found to potentially contain metal pieces. Rich Products Corporation is a Buffalo, New York-based company and the maker of the Farm Rich…
Alembic Pharmaceuticals Shares Jump 3% After US FDA Tentatively Approves Larotrectinib Capsules
Alembic Pharmaceuticals shares rose nearly 3% in trading after the company announced that the US Food and Drug Administration (FDA) granted tentative approval for its Larotrectinib capsules. The development marks a positive milestone for the Indian pharmaceutical company as it continues to expand its presence in the regulated US market. The announcement triggered strong investor…
Halma FY Profit Jumps 22% as Revenue Rises 15% to £2.58B, but Single Customer Now Drives 20% of Sales
Halma reported another year of strong growth on June 11, 2026, with annual revenue rising 15% to £2.58 billion and profit increasing 22%. The UK-based safety and technology group benefited from rising demand for photonics products used in AI-powered data centers. While the record results highlight the company’s growth momentum, investors are paying close attention…
Ryanair Holdings plc (RYAAY) Falls 3.88% as CMA Investigates £8 Mandatory Child Seat Charges
Ryanair Holdings plc faced pressure in the market after shares fell 3.88% following news that the United Kingdom’s Competition and Markets Authority (CMA) launched an investigation into the airline’s family seating policy. The probe focuses on whether the low-cost carrier’s mandatory family seat charge of approximately £8 per flight is fair under consumer protection laws….
Top 5 Growth Tech Stocks in the NASDAQ, NYSE to Watch in June 2026 (AI and Semiconductor Leaders)
The market for growth tech stocks on the NASDAQ and NYSE is moving fast in June 2026. AI infrastructure, photonic chips, haptic licensing, and agentic commerce are all pulling investor attention toward a new group of technology companies. Whether you are a long-term investor or an active trader, knowing which stocks have real momentum backed…
Hindustan Unilever Ltd Jumps 2.75% as JPMorgan Flags Premiumisation Growth
₹2,191.50. Up ₹58.70. In a single session. Hindustan Unilever Ltd (HINDUNILVR.NS) delivered one of its sharpest single-day moves in months on June 10, 2026, with the stock climbing 2.75% as fresh brokerage commentary on India’s premiumisation trend landed at exactly the right time. Hindustan Unilever Ltd gained for a fifth straight session. The stock trading…
Lloyds Banking Group PLC (LON: LLOY) Falls 0.12% as Stock Dips to 98.06 GBX Amid £5M Buyback
Lloyds Banking Group PLC shares slipped 0.12% to 98.06 GBX on June 10, 2026, as investors reacted to mixed sentiment in the UK banking sector. The move came even as the bank continued its £5M daily share buyback programme aimed at supporting shareholder value. Trading remained steady but cautious throughout the session. Market participants are…
Parabilis Medicines Targets Up to $2.3 Billion Valuation in Expanded U.S. IPO Amid Biotech Market Rally
Parabilis Medicines is aiming for a valuation of nearly $2.3 billion through an expanded U.S. initial public offering, highlighting renewed investor confidence in the biotechnology sector. The Cambridge, Massachusetts-based company increased the size of its offering as demand for biotech IPOs continues to improve following a challenging period for the industry. The company now plans…